Replies to post #199 on Achaogen Inc. (fka AKAOQ)

[apollo1452]

Short sellers running out of shares to short.

FIS Astec reported that Achaogen’s utilization rate is now 96 percent of available shares to sell short & that borrowing costs are in the double-didgits. AKAO just received a 15-0 unanimous AdComm vote In Favor of cUTI approval for Plazomicin at the June 25 PDUFA.

Looks to me like the holders of 14,173,200 shorted shares (over 10 days to cover lol) have massively overplayed their hand & are now up to their eyeballs in a mountain of short covering feces. Margin calls are On Deck...